Overview

D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation (DCSSmoking)

Status:
Withdrawn
Trial end date:
2015-07-15
Target enrollment:
Participant gender:
Summary
This study examines whether isolated doses of D-cycloserine enhance the efficacy of CBT for smoking cessation.
Phase:
Phase 2
Details
Lead Sponsor:
Boston University
Boston University Charles River Campus
Treatments:
Cycloserine